Going beyond Integration: The Emerging Role of HIV-1 Integrase in Virion Morphogenesis

被引:23
|
作者
Elliott, Jennifer L. [1 ]
Kutluay, Sebla B. [1 ]
机构
[1] Washington Univ, Dept Mol Microbiol, Sch Med, St Louis, MO 63110 USA
来源
VIRUSES-BASEL | 2020年 / 12卷 / 09期
关键词
HIV-1; integrase; maturation; integrase– RNA interactions; protein– IMMUNODEFICIENCY-VIRUS TYPE-1; RETROVIRAL DNA INTEGRATION; MURINE LEUKEMIA-VIRUS; STRUCTURE-BASED MUTAGENESIS; GENE-EXPRESSION REQUIRES; AMINO-ACID-RESIDUES; X-RAY STRUCTURES; VIRAL-DNA; REVERSE TRANSCRIPTION; NUCLEOCAPSID PROTEIN;
D O I
10.3390/v12091005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The HIV-1 integrase enzyme (IN) plays a critical role in the viral life cycle by integrating the reverse-transcribed viral DNA into the host chromosome. This function of IN has been well studied, and the knowledge gained has informed the design of small molecule inhibitors that now form key components of antiretroviral therapy regimens. Recent discoveries unveiled that IN has an under-studied yet equally vital second function in human immunodeficiency virus type 1 (HIV-1) replication. This involves IN binding to the viral RNA genome in virions, which is necessary for proper virion maturation and morphogenesis. Inhibition of IN binding to the viral RNA genome results in mislocalization of the viral genome inside the virus particle, and its premature exposure and degradation in target cells. The roles of IN in integration and virion morphogenesis share a number of common elements, including interaction with viral nucleic acids and assembly of higher-order IN multimers. Herein we describe these two functions of IN within the context of the HIV-1 life cycle, how IN binding to the viral genome is coordinated by the major structural protein, Gag, and discuss the value of targeting the second role of IN in virion morphogenesis.
引用
收藏
页数:22
相关论文
共 50 条
  • [41] Arylamide inhibitors of HIV-1 integrase
    Zhao, H
    Neamati, N
    Mazumder, A
    Sunder, S
    Pommier, Y
    Burke, TR
    JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (08) : 1186 - 1194
  • [42] Thiazolothiazepine inhibitors of HIV-1 integrase
    Neamati, N
    Turpin, JA
    Winslow, HE
    Christensen, JL
    Williamson, K
    Orr, A
    Rice, WG
    Pommier, Y
    Garofalo, A
    Brizzi, A
    Campiani, G
    Fiorini, I
    Nacci, V
    JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (17) : 3334 - 3341
  • [43] Authentic HIV-1 integrase inhibitors
    Liao, Chenzhong
    Marchand, Christophe
    Burke, Terrence R., Jr.
    Pommier, Yves
    Nicklaus, Marc C.
    FUTURE MEDICINAL CHEMISTRY, 2010, 2 (07) : 1107 - 1122
  • [44] Structure and function of HIV-1 integrase
    Chiu, TK
    Davies, DR
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2004, 4 (09) : 965 - 977
  • [45] Raltegravir: an integrase inhibitor for HIV-1
    Evering, Teresa H.
    Markowitz, Martin
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2008, 17 (03) : 413 - 422
  • [46] Characterization of natural polymorphic sites of the HIV-1 integrase before the introduction of HIV-1 integrase inhibitors in Germany
    Meixenberger, Karolin
    Yousef, Kaveh Pouran
    Somogyi, Sybille
    Fiedler, Stefan
    Bartmeyer, Barbara
    von Kleist, Max
    Kuecherer, Claudia
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 : 157 - 157
  • [47] Stability of HIV-1 integrase–ligand complexes: the role of coordinating bonds
    F. V. Grigoriev
    A. Yu. Golovacheva
    A. N. Romanov
    O. A. Kondakova
    A. V. Sulimov
    M. A. Smolov
    M. B. Gottikh
    V. B. Sulimov
    A. A. Bogolyubov
    Yu. V. Kuznetsov
    M. D. Dutov
    Structural Chemistry, 2012, 23 : 185 - 195
  • [48] Specific inhibition of human immunodeficiency virus type 1 (HIV-1) integration in cell culture: Putative inhibitors of HIV-1 integrase
    Vandegraaff, N
    Kumar, R
    Hocking, H
    Burke, TR
    Mills, J
    Rhodes, D
    Burrell, CJ
    Li, P
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (09) : 2510 - 2516
  • [49] Raltegravir, an HIV-1 integrase inhibitor for HIV infection
    Cabrera, Cecilia
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2008, 9 (08) : 885 - 898
  • [50] Effectiveness of Gene Delivery Targeting HIV-1 Integrase in Inhibiting HIV Integration: Lack of HIV-1 Genomes in T-Lymphocytes during Repeated Challenges with HIV-1
    Marusich, Elena I.
    Mitchell, Christine B.
    Strayer, David S.
    MOLECULAR THERAPY, 2006, 13 : S233 - S233